Author:
Spanakis Nikolaos,Tsiodras Sotirios,Haagmans Bart L.,Raj V. Stalin,Pontikis Kostantinos,Koutsoukou Antonia,Koulouris Nikolaos G.,Osterhaus Albert D.M.E.,Koopmans Marion P.G.,Tsakris Athanassios
Subject
Pharmacology (medical),Infectious Diseases,Microbiology (medical),General Medicine
Reference30 articles.
1. Epidemiological update: Middle East respiratory syndrome coronavirus (MERS-CoV);European Centre for Disease Prevention and Control,2014
2. What are our pharmacotherapeutic options for MERS-CoV?;Al-Tawfiq;Expert Rev Clin Pharmacol,2014
3. Ribavirin and interferon therapy in patients infected with the Middle East respiratory syndrome coronavirus: an observational study;Al-Tawfiq;Int J Infect Dis,2014
4. Therapeutic options for Middle East respiratory syndrome coronavirus (MERS-CoV)—possible lessons from a systematic review of SARS-CoV therapy;Momattin;Int J Infect Dis,2013
5. Clinical Decision Making Tool for Treatment of MERS-CoV v.1.1, 29 July, 2013. Public Health England. http://webarchive.nationalarchives.gov.uk/20140714084352/http://www.hpa.org.uk/webc/HPAwebFile/HPAweb_C/1317139281416 [accessed 11 September 2014].
Cited by
98 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献